QuickView for nitric oxide transmembrane transporter activity (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
5. L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens

There were no matches for nitric oxide transmembrane transporter activity

1. Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis
2. Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …
3. Evaluation of Acute and Subacute Effects of Nicotine Free Electronic Cigarette(NCFE) Vapors
4. Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.